Completed NA INTERVENTIONAL NCT00287300

Efficacy and Safety of Azithromycin and Artesunate in Pregnant Women

A Pilot Randomized Controlled Trial of Azithromycin or Artesunate Added to Sulphadoxine Pyrimethamine as Therapy for Malaria in Pregnancy

Sponsor: Centers for Disease Control and Prevention

Conditions Malaria

Interventions Artesunate Azithromycin Sulfadoxine-Pyrimethamine

Updated 4 times since 2017 Last updated: Feb 3, 2006 Started: Sep 30, 2003 Completion: Aug 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00287300, this NA trial focuses on Malaria and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 4 times since 2003, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centers for Disease Control and Prevention
University of North Carolina

Data source: University of North Carolina, Chapel Hill

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Blantyre, Malawi